University of Ioannina
Διερεύνηση της πιθανής αντικαρκινικής δράσης των αντιψυχωσικών σε πειραματικά μοντέλα μη μικροκυτταρικού καρκίνου του πνεύμονα
Abstract
dc:descriptionCancer is a disease occurs abnormal cell proliferation independently of mitogenic stimuli. It is classified as the second leading cause of death worldwide after cardiovascular diseases and according to the World Health Organization is the main cause of 1 in 6 recorded deaths. Environmental and chemical substances are usually responsible for causing mutations in genes that regulate the course of the cell cycle. Among the wide-spread types of cancer in developed countries is lung cancer, which is also the first cause of death in men. Based on the form of the cancer cells, it is categorized into non-small cell and small cell lung cancer, with the non-small cell type occurring in 85% of lung cancer diagnoses. The main cause of occurrence is cigarette smoke which leads to mutations in oncogenes, tumor suppressor genes as well as genes regulating the cell cycle. The best-known signaling pathways involved in the induction of cell growth and cell proliferation are EGF/RAS/RAF/MEK/ERK and PI3K/AKT, which are overactivated in many types of cancer, including lung cancer. In the therapeutic strategies against various types of cancer, various cytotoxic and cytostatic agents are used which aim either at the direct killing of cancer cells or indirectly at signaling related to cell survival. However, despite the multitude of anti-neoplastic drugs, none of them has managed to significantly increase life expectancy. Thus, costs are constantly increasing, and efficiency remains low. Drug repurposing is a strategy of finding new uses for already existing and approved drugs, which aims to immediately enter the market, drugs with already known toxicity and mechanism of action, thus saving time and costs. For this reason, a series of epidemiological studies which correlate schizophrenia with the occurrence of several types of cancer are of considerable interest. Specifically, it has been shown that people with schizophrenia under medication show significantly lower rates of various types of cancer, including lung cancer. For the treatment of schizophrenia, 1st and 2nd generation antipsychotic drugs are used, which share as a com-mon feature the antagonism of D2-dopaminergic receptors. The aim of this thesis is to investigate the possible anti-cancer effect of antipsychotic drugs in non-small cell lung cancer and their possible beneficial effect on the already known anti-cancer effect of antineoplastic drugs. To achieve the goal, in vitro (A549, H1299 and H460 cancer cells) and in vivo (xenografted mice) experimental models of non-small cell lung cancer used in which the effect of antipsychotics in combination with antineoplastics on cell proliferation was investigated and cell signaling. The role of D2-dopaminergic receptors in this action was also evaluated. The results of the study showed that antipsychotics exert a weak effect on the inhibition of cell proliferation but enhance the antitumor effect of cisplatin and paclitaxel in in vitro experimental models of lung cancer. Silencing of D2-receptors appears to affect the effect of aripiprazole and pimozide on H460 cell proliferation and cell signaling, since inhibition of cell growth and activation of ERK, CREB and GSK3 pathways ob-served in wtH460 is not observed in siH460 cells. Regarding the in vivo results, pimozide delays the formation of tumors in xenografted mice and significantly reduces their size, possibly through the reduction of S6 kinase activity and the activation of the transcription factor FOXO1, thus directly affecting the PI3K/ AKT/S6/mTOR and PI3K/AKT/FOXO1. Aripiprazole is also effective in reducing tumors while maintaining the health of mice, unlike pimozide, which showed in-creased toxicity. The action of aripiprazole is possibly due to the inhibition of the ERK signaling pathway in tumors, which is linked to cell growth, but also to the inhibition of GSK3β activity. In conclusion, the findings of the present preclinical study show the potential anticancer activity of some antipsychotic drugs in various forms of cancer, including non-small cell lung cancer. Aripiprazole seems to be of particular interest, especially when combined with paclitaxel, a case that should be thoroughly investigated in the context of clinical studies.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Andriopoulou, Eirini-Christina
- Ανδριοπούλου, Ειρήνη-Χριστίνα
Subjects
dc:subject × 11Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/57792